SCHEMBL13971180

SCHEMBL13971180

CCCCOc1cc(Br)ccc1/C=N/c1ccc(C)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 3/20 0.45
▸ MAPT P10636 4/20 0.44
▸ MEN1 O00255 3/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ LMNA P02545 6/20 0.43
▸ ALDH1A1 P00352 4/20 0.43
▸ CYP1A2 P05177 2/20 0.43
▸ CYP2C9 P11712 2/20 0.43
▸ CYP2C19 P33261 2/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ RECQL P46063 1/20 0.43
▸ GAA P10253 3/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ THRB P10828 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ MAOB P27338 3/20 0.40
▸ TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13971346 0.89 HPGD (0.44) HPGDMAPTMEN1KMT2ALMNA
SCHEMBL14206353 0.89 GAA (0.46) HPGDMAPTMEN1KMT2ALMNA
SCHEMBL13786439 0.88 MAOB (0.46) HPGDMAPTMEN1KMT2ALMNA
SCHEMBL14221634 0.86 MAOB (0.46) HPGDMAPTMEN1KMT2ALMNA
SCHEMBL13971076 0.85 GAA (0.46) HPGDMAPTMEN1KMT2ALMNA
SCHEMBL13956243 0.80 MAOB (0.58) MAPTLMNAALDH1A1CYP1A2CYP2C9
SCHEMBL14206850 0.76 GAA (0.52) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL1878476 0.76 HPGD (0.50) HPGDMAPTMEN1KMT2ALMNA
SCHEMBL14035606 0.75 GAA (0.46) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL2771758 0.75 PTGDR2 (0.48) HPGDMAPTMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090005321-A1 Phenylazetidinone Derivatives MICROBIA, INC. (US) 2009-01-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090005321-A1 Phenylazetidinone Derivatives TYR, AAAS, FANCD2 HPGD 57/4885MAPT 1936/4885MEN1 1686/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback